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Abstract
Background: Humanized mice able to reconstitute a surrogate human immune system (HIS) can be used for studies on
human immunology and may provide a predictive preclinical model for human vaccines prior to clinical trials. However,
current humanized mouse models show sub-optimal human T cell reconstitution and limited ability to support
immunoglobulin class switching by human B cells. This limitation has been attributed to the lack of expression of Human
Leukocyte Antigens (HLA) molecules in mouse lymphoid organs. Recently, humanized mice expressing HLA class I
molecules have been generated but showed little improvement in human T cell reconstitution and function of T and B cells.
Methods: We have generated NOD.Rag1KO.IL2RccKO mice expressing HLA class II (HLA-DR4) molecules under the I-E
d
promoter that were infused as adults with HLA-DR-matched human hematopoietic stem cells (HSC). Littermates lacking
expression of HLA-DR4 molecules were used as control.
Results: HSC-infused HLA-DR4.NOD.Rag1KO.IL-2RccKO mice developed a very high reconstitution rate (.90%) with long-
lived and functional human T and B cells. Unlike previous humanized mouse models reported in the literature and our
control mice, the HLA-DR4 expressing mice reconstituted serum levels (natural antibodies) of human IgM, IgG (all four
subclasses), IgA, and IgE comparable to humans, and elicited high titers of specific human IgG antibodies upon tetanus
toxoid vaccination.
Conclusions: Our study demonstrates the critical role of HLA class II molecules for development of functional human T cells
able to support immunoglobulin class switching and efficiently respond to vaccination.
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Introduction
Early models of humanized mice used for HIS reconstitution
were generated in the late 1980s by infusion of human peripheral
blood mononuclear cells into T- and B-cell deficient rodents such
as scid mice [1–5], a strain derived from CB.17 mice that bears a
mutation in the protein kinase, DNA-activated catalytic polypep-
tide (prkdc) [6]. The level of reconstitution in scid mice was
however low (,1%) and consisted mainly of human T cells, as
very few human B cells were able to survive. These humanized
mice also faced the challenge of human T cell functional
impairment upon vaccination, and in some cases development of
graft versus host disease (GVHD) as a consequence of human T
cell reactivity against the mouse MHC antigens [4,5].
To increase the level of human cell reconstitution and to
overcome GVHD, investigators used scid mice infused with human
hematopoietic stem cells (HSC) [3,7,8]. This model known as Hu-
HSC-scid was able to develop human B and myeloid cells but the
life-span of these human cells was relatively short, and the model
also failed to develop critical compartments of the human immune
system such as T cells. This limitation was mostly attributed to the
destructive activity of mouse natural killer (NK) cells, since the
development of mouse NK cells is not affected by the scid mutation
[6]. Inbreeding the scid mutation into the non-obese diabetic
(NOD) mouse increased the rate of human cell reconstitution upon
HSC infusion due to the reduced number and functional
impairment of NK cells in the NOD mouse [9,10]. Yet, the
NOD.scid mouse model still did not support high rates or long-
lasting reconstitution with human immune cells, nor did it allow
development of functional human T and B cells [11].
The generation of mice bearing a mutation in the IL2R gamma
chain(IL2Rcc) was a major breakthrough inthe field,asthis strainis
devoid of NK cells [12]. Genetic stocks of NOD.scid.IL2RccKO,
NOD.RagKO.IL2RccKO, and BALB/c.RagKO.IL2RccKO mice
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human HSCs [13–17]. Although both HSC-infused newborn and
adult mice were highly reconstituted with human B cells, the
development of B cells was arrested in an early stage and did not
suffice for reconstitution of human immunoglobulins (natural
antibodies) in serum, other than IgM [18]. Newborn recipient mice
weremuchmoreefficient for developmentof human T cells thanthe
adult recipients [19], but the human T cells were functionally
impaired, as their response to in vitro polyclonal T cell stimulation
with anti-CD3/CD28 Abs or PMA/ionomycin was poor [18].
Studies from several laboratories further indicated that these mice
were sub-optimal, or alternatively failed to elicit cellular and/or
humoral responses upon infection or vaccination [15,20–22].
Impairment of human T and B cell function in HSC-
reconstituted IL2RccKO genetic stocks has been attributed to
the lack of expression of Human Leukocyte Antigens (HLA) in the
mouse thymus, since HLA molecules are required for development
of human T cells [23] that in turn, are essential for stimulation of B
cells towards immunoglobulin class switching and antibody
secretion [24]. Indeed, mice transplanted with human fetal
thymus and liver under the kidney capsule and at the same time
infused with human HSCs (a model known as BLT mouse –Bone
marrow, Liver, Thymus) [25] showed significant improvement in
the function of human T and B cells, as these mice were able to
elicit specific IgM responses upon vaccination [25,26].
Recently, humanized mice expressing HLA class I (HLA-A2)
molecules on the NOD.scid.IL2RccKO background have been
generated [27–29]. Contrary to expectations, the HLA-A2
transgenic (Tg) mice showed similar rates of human T cell
reconstitution as non-Tg littermates [28], though some of the T
cell reconstituted mice were able to elicit HLA-A2-restricted CD8
T cell responses upon infection with Epstein Barr or dengue virus
[27–29]. However, the function of human B cells was not
improved by the transgenic expression of HLA-A2 molecules in
HSC-recipient mice, as these mice were unable to elicit specific
IgG antibodies [27–29].
Herein, we show that a newly-generated strain of NOD.Rag1-
KO.IL2RccKO mice expressing HLA-DR*0401 molecules (here-
after referred to as DRAG mice) develop high rate of human T
and B cell reconstitution upon infusion of HLA-DR-matched HSC
during adulthood. Both CD4
+ and CD8
+ human T cell subsets as
well as human B cells are highly functional as indicated by their
ability to secrete human cytokines, reconstitute serum levels of
human IgM, IgG, IgA, and IgE, and elicit specific IgG antibodies
upon vaccination. The results demonstrate that expression of HLA
class II molecules in humanized mice supports the development of
a functional human adaptive immune system.
Results
DRAG mice infused with HLA-DR-matched HSC are highly
reconstituted with human T cells
Early lymphoid precursors derived from hematopoietic stem
cells in the bone marrow migrate to the thymus where they
differentiate into CD4
+CD8
+ double positive (DP) cells. DP cells
undergo positive or negative selection upon recognition of self-
peptides presented by thymic epithelial cells in the context of
MHC molecules [23], with positively-selected DP thymocytes
differentiating into CD4
+ or CD8
+ single positive (SP) thymocytes
that then repopulate peripheral lymphoid organs.
Thymic selection is a physiological process that prevents
autoimmunity by eliminating self-reactive T cells and at the same
time generates a broad spectrum of T cells reactive against foreign
antigens.
To test the hypothesis that constitutive expression of HLA class
II molecules in humanized mice rescues development of human
CD4 T cells, we generated NOD.Rag1KO.IL2RccKO mice
expressing HLA-DR4 (0401) molecules (hereafter referred to as
DRAG mice) (Fig. 1A upper panel). Four-to-six week-old DRAG
mice were infused with CD34
+ HSC from HLA-DR*0401-positive
umbilical cord bloods and monitored by FACS for development of
human T cells in the peripheral blood. As a specificity control, we
used NOD.Rag1KO.IL2RccKO littermates lacking expression of
HLA-DR4 molecules (Fig. 1A, lower panel) that were infused with
HSC from the same donors. As illustrated in figure 1B, the rate of
human T cell reconstitution in DRAG mice was considerably
higher than in control mice, since 14 out of 15 (93.3%) DRAG
mice developed human T cells by 25 weeks post-infusion with
HSC as compared to only 4 out of 11 (36.4%) control littermates
developing human T cells. In addition, the frequency of human T
cells in the blood of reconstituted DRAG mice (n=14) was
considerably higher than in the reconstituted control littermates
(n=4) (Fig. 1C, p=0.0044, Table S1). Thus, the results
demonstrated that expression of HLA-DR4 molecules in DRAG
mice promoted development of human T cells.
T cell-reconstituted DRAG (n=14) and control mice (n=4)
developed both CD4 and CD8 T cells in blood, but the frequency
of CD4 T cells was significantly higher in DRAG mice (Fig. 1D,
p=0.0032). Of note, the frequency of blood circulating CD4 T
cells in DRAG mice was comparable to that of human volunteers
(Fig. 1D, upper and lower panels). On the other hand, the
frequency of human CD8 T cells in blood of both groups of mice
was similar (Fig. 1D, p=0.36) and at the same time lower than
that in blood of human volunteers.
Since T cells are developed in thymus from bone marrow
precursors, we next investigated the kinetics of human cell
reconstitution in bone marrow, thymus, and spleen of DRAG
mice at 2 and 6 months post-infusion of HSC. At 2 months post-
infusion of HSC, the bone marrow of DRAG mice (n=4) showed
much higher numbers of CD45
+ and CD34
+ cells than the control
mice (n=4) (Fig. 2A). CD45 is a type I transmembrane protein
expressed in all human hematopoietic cells except erythrocytes
and plasma cells, and CD34 is a marker specific for human HSCs.
The thymus of DRAG mice also showed considerably higher
numbers of human CD45
+ cells than the control mice, with most
CD4
+CD8
+ DP, followed by CD4
+ SP and CD8
+ SP (Fig. 2B). Of
note, all DRAG mice (n=4) used for these analyses had human
cells in thymus but only 1 out of 4 control mice had human cells in
thymus. Thus, these results indicated that expression of HLA-DR4
molecules in DRAG mice favored HSC engraftment in bone
marrow and more importantly, promoted the development of
human thymocytes.
At 6 months post-infusion of HSC, the bone marrow of DRAG
and control mice contained similar numbers of human CD45
+ and
CD34
+ cells (Fig. 2A), but still the thymuses from control mice
were poorly reconstituted with human thymocytes (Fig. 2B, right
panel). Furthermore, the spleens of all DRAG mice examined
(n=4) contained mature human T cells (Fig. 2C), of which most
were CD4 T cells (23.8%) and, to a lower extent, CD8 T cells
(5.0%) (CD4:CD8 average=5.2). The frequency of CD4 and CD8
T cells in human spleen is approximately 17% and 14%,
respectively [30]. On the other hand, the control mice (n=2)
that were selected based on the presence of human T cells in blood
had human T cells in the spleen as well (Fig. 2C), but the CD4 T
cell frequency (4.6%) was considerably lower than that in spleens
of DRAG mice (CD4:CD8 average ratio=1.5). Also, among
control mice showing no reconstitution with human T cells in
blood (n=3) all lacked human T cells in spleen (data not shown).
HLA Class II and Humanized Mice
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molecules in DRAG mice promoted repopulation of human T
cells in the periphery.
CD4
+FOXP3
+ regulatory T cells (Tregs) are the archetype of
immune regulatory cells that are naturally developed in the
thymus [31]. Tregs serve as ‘‘guardians’’ of the immune system by
maintaining immune homeostasis and at the same time restricting
the CD4 and CD8 T-cell responses as well as humoral responses to
self and non-self antigens. The frequency of Tregs in human blood
is 2–5% among the CD4 T cell population [32]. At 6 months after
infusion of HSC, a much higher frequency (p=0.021) of human
CD4
+FOXP3
+ Tregs was detected in spleens of DRAG mice as
compared to control mice (Fig. 3A). Thus, our results indicated
that a major regulatory cell compartment (human CD4
+FOXP3
+
Tregs) was also reconstituted in DRAG mice upon infusion of
HLA-DR-matched HSC.
Dendritic cells (DCs) are critical components of the innate
immune system due to their potent ability to process antigen and
present immunogenic peptides to T cells for activation [33]. The
frequency of DCs in human spleen has been estimated as 2.3% of
the mononuclear population [34]. As illustrated in figure 3B, both
DRAG and control mice developed human DCs
(CD11c
+CD19
2). The frequency of human DCs in spleens of
DRAG mice (2.9%) was slightly higher than that in control mice
(1.5%), though it did not reach statistical significance.
Natural killer (NK) cells are characterized by expression of
CD16, an immunoglobulin Fc receptor that allows them to
eliminate target cells through a process known as ‘‘antibody-
dependent-cell-cytotoxicity’’ or ADCC [35]. The frequency of NK
cells in human spleen has been estimated as 15% [30]. As shown
in figure 3B, the numbers of human NK cells in both DRAG and
control mice were insignificant (0.05% vs. 0.07%), which indicated
Figure 1. Kinetics of human T cell reconstitution in blood of DRAG mice. Panel A, FACS analysis of splenic, thymic, and bone marrow cells
from naı ¨ve (non-HSC infused) DRAG and control mice (n=3) stained with HLA-DR antibodies. Groups of DRAG (n=15) and control (n=11) mice that
were infused intravenously with 80,000 enriched-HSC (CD34
+) cells from umbilical cord blood of HLA-DR4 (*0401) newborns were examined in
peripheral blood by FACS using anti-human CD3, CD4, and CD8. Panel B, percentage of human T cell reconstituted mice at various time points post-
infusion of HSC. Fisher exact test indicated that the rate of human T-cell reconstitution in DRAG mice (14 out of 15) was significantly superior to that
in control mice (4 out of 11) (p=0.0025). Panel C, frequency of human CD3
+ T cells in blood of reconstituted DRAG (n=14) and control (n=4) mice.
The cut-off for positive human CD3
+ T cells was calculated as three times the standard deviation over the background levels of cells from naı ¨ve (non-
HSC infused) DRAG mice that were stained with anti-human CD3 (.0.17%). Ranges are indicated over the plots. Mann-Whitney test indicated that the
frequency of human T cells in blood of DRAG mice was significantly higher than that in control mice (p=0.0044). Panel D, frequency of human CD4
and CD8 T cells in blood of T cell reconstituted DRAG mice (n=14) and control mice (n=4) at 25 weeks post-infusion of HSC (upper two panels).
Lower histograms shows frequencies of CD4 and CD8 T cells in human blood (n=2). P values were calculated using the Mann-Whitney test.
doi:10.1371/journal.pone.0019826.g001
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human NK cells.
In aggregate, these results demonstrated that expression of
HLA-DR4 molecules in DRAG mice favored engraftment of HSC
in bone marrow, homing and development of bone-marrow-
derived human T cell precursors in thymus, and proficient
repopulation of peripheral lymphoid organs with mature CD4 and
CD8 T cells. Expression of HLA-DR4 molecules however did not
improve development of human NK cells.
Human CD4 and CD8 T cells developed by DRAG mice
are functional
Previous studies in HSC-infused NOD and BALB/c genetic stocks
bearing the IL2RccKO mutation revealed a functional impairment
of human T cells reconstituted in these strains, as they responded
weakly to polyclonal stimulation with anti-human CD3/CD28
antibodies or PMA/ionomycin [18]. It was thus important to
investigate whether expression of HLA-DR4 molecules in DRAG
mice may have rescued the function of human T cells. As illustrated
in figure 4A&B, human T cells from spleens of DRAG mice (n=4)
responded vigorously to CD3/CD28 or PMA/ionomycin stimula-
tion as indicated by secretion of high levels of human cytokines in cell
cultures. Noteworthy, the magnitude of T cell responses in DRAG
mice was comparable to that of human PBMCs from healthy
volunteers. In contrast, human T cells from the spleens of control
mice (n=2) responded poorly to CD3/CD28 or PMA/ionomycin
stimulation (Fig. 4A&B). These results demonstrated that the human
T cell compartment reconstituted in DRAG mice is functional.
Since DRAG mice express HLA class II (DR4) molecules but
not HLA class I molecules, which is the restriction element for
thymic selection of human CD8 T cells, we next compared the
function of human CD4 vs. CD8 T cells developed by DRAG mice
in a well-controlled in vitro system. For this comparison, spleen cells
from DRAG mice were depleted of either CD4 T cells, CD8 T
cells, or both T cell subsets using antibody-coated magnetic beads
followed by stimulation with PMA/ionomycin. As illustrated in
figure 4C, depletion of human CD4 T cells partially reduced the
secretion of IL-2 and IFNc as compared to that of non-depleted
splenic cells, and abrogated secretion of TNFa. Depletion of
human CD8 T cells from spleens also reduced the secretion of IL-
2 and IFNc, but had little effect on secretion of TNFa. In addition,
positively-isolated CD4 T cells from spleens of DRAG mice
secreted high levels of IL-2, IFNc, and TNFa upon stimulation
with PMA/ionomycin, and positively-isolated CD8 T cells
secreted IL-2 and IFNc, but not TNFa. It is know that CD8 T
cells secrete little or no TNFa upon PMA/ionomycin stimulation
[36]. These results indicated that both human CD4 and CD8 T
cells developed by DRAG mice are functional as they respond to
stimulation through TCR and non-TCR signaling pathways.
DRAG mice infused with HLA-DR-matched HSC are highly
reconstituted with human B cells
The longitudinal FACS analysis in blood of DRAG and
control mice using anti-human CD19 revealed that the rate of
human B-cell reconstitution was similar between the two strains.
Thus, 14 out of 15 (93.3%) DRAG mice and 9 out of 11 (81.8%)
Figure 3. Expression of HLA-DR4 molecules in DRAG mice fosters development of Tregs but not of myeloid and natural killer cells.
Panel A, frequency of CD4
+FOXP3
+ Tregs among splenic T cells from DRAG (n=4) and control (n=2) mice that were examined at 6 months post-
infusion of HSC (p=0.021). Panel B, frequency of dendritic cells (CD11c
+CD19
2) and NK cells (CD16
+CD3
2) in spleens of DRAG (n=3) and control
(n=2) mice at 6 months post-infusion of HSC. The cut-off for positive cells was 0.09% for DCs, and 0.01% for NK cells. P values were calculated using
Independent Samples t-test.
doi:10.1371/journal.pone.0019826.g003
Figure 2. Kinetics of human T cell reconstitution in peripheral lymphoid organs. Groups of DRAG and control mice (n=4) were euthanized
at 2 months post-infusion of HSC and bone marrow (panel A) and thymus (panel B) were examined for the presence of human cells by FACS using
specific antibodies. All DRAG mice reconstituted bone marrow and thymus with human cells. All control mice reconstituted bone marrow with
human cells, though at much lower frequencies than DRAG mice, and only 1 of them was able to reconstitute thymus with human cells. No
significant human T cell reconstitution was detected in spleens of DRAG or control mice at this time point (data not shown). Additional groups of
DRAG (n=4) and control (n=2) mice that showed human T cells in blood at 6 months post-infusion of HSC, were examined by FACS in bone marrow
(panel A), thymus (panel B) and spleen (panel C). Data represent mean values of mice analyzed individually. Ranges are indicated over the plots. P
values were calculated using Independent Samples t-test. Of note, control mice (n=3) that did not have human T cells in blood, also showed absence
of human T cells in thymus and spleen (data not shown).
doi:10.1371/journal.pone.0019826.g002
HLA Class II and Humanized Mice
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+) cells by
10 weeks after HSC infusion (Fig. 5A). Although not statistically
significant (p=0.31), 25 weeks after infusion of HSC the overall
frequency of blood circulating human B cells in DRAG mice was
slightly lower than in control mice (Fig. 5B, Table S1).
Noteworthy, spleens of DRAG mice contained similar numbers
of human B cells as compared to control mice (B cell frequency:
47.9%, range [45.9–50] vs. 60% [55–65.9]; total number of B
cells/spleen: 5.5610
661.95 vs. 6.35610
662.75, respectively).
This indicated that expression of HLA-DR4 molecules in DRAG
mice did not improve significantly the reconstitution with human
B cells in the peripheral blood on in the spleen as compared to
control mice.
Human B cells developed by DRAG mice are functional
and reconstitute plasma levels of all human
immunoglobulin classes
The major function of B cells is to secrete immunoglobulins
(antibodies) that can be detected in blood and body fluids. The
function of immunoglobulins is to neutralize and eliminate
viruses, bacteria, and parasites as well as to control the
homeostatic growth of commensal bacteria in the intestinal tract
[24]. In mammalians, there are five classes of immunoglobulins,
namely IgD, IgM, IgG, IgA, and IgE, from which IgM and IgG
are the most abundant in blood. Previous studies in various
humanized mouse models revealed an impaired function of
human B cells reflected by poor reconstitution of human IgM
serum levels and limited ability to undergo immunoglobulin class
switch and to secrete immunoglobulins other than IgM
[15,18,20–22]. Thus, we investigated the kinetics of human
immunoglobulin reconstitution in blood of DRAG mice. As
illustrated in figure 5C, the levels of human IgM in plasma from
B cell reconstituted DRAG mice (n=14) were significantly higher
than those from reconstituted control mice (n=9) (p=0.0002). In
addition, the DRAG mice were able to reconstitute plasma IgG
whilst control mice failed to do so (Fig. 5D, Table S1).The results
indicated that the mechanism of immunoglobulin class switch was
preserved in DRAG mice. The human identity of Ig heavy and
Figure 4. Human T cells developed by DRAG mice are functional. At 6 months post-infusion of HSC, splenic cells (3610
5) from DRAG (n=4)
and control mice (n=2) as in figure 2, were stimulated for 24 h with anti-human CD3/CD28 Abs (panel A) PMA/ionomycin (panel B) or left
unstimulated, and cytokines secreted in supernatants were measured by Luminex. Non-stimulated cells secreted insignificant levels of human
cytokines (,50 pg/ml). Data represent mean values of mice analyzed individually over the background levels of non-stimulated cultures. Ranges are
indicated over the plots. T cells from DRAG mice secreted significantly higher levels of IL-2 upon stimulation with CD3/CD28 Abs or PMA/ionomycin
as compared to control mice (p values=0.013 and 0.025, respectively using the Independent sample t-test). Panel C, cell-depleted spleens or
positively isolated CD4 T and CD8 T cells from pooled spleens of two additional DRAG mice were stimulated in vitro with PMA/ionomycin for 24 h or
left unstimulated. Non-stimulated cell cultures produced insignificant levels of human cytokines (,50 pg/ml). Data represent the mean 6 SD of
duplicated samples over the background levels of non-stimulated cells. Similar results were obtained in a second independent experiment.
doi:10.1371/journal.pone.0019826.g004
HLA Class II and Humanized Mice
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immunoelectrophoresis (Fig. 6A).
Human IgG class comprises four different subclasses that differ
in structure and biological functions, namely (i) ability to cross
placenta, (ii) ability to activate the complement cascade and (iii)
affinity binding to Fc receptors expressed on phagocytic cells [37].
As illustrated in figure 6C, DRAG mice reconstituted plasma levels
of all human IgG subclasses, with IgG2 as the most prevalent
followed by IgG1, IgG3 and IgG4, whereas in the human blood
the most prevalent subclass is IgG1, followed by IgG2, IgG3 and
IgG4 [36]. In addition, 12 out of 14 (85.7%) DRAG mice
reconstituted plasma levels of human IgA (Fig. 6D) and 7 out of 14
(50%) reconstituted plasma levels of human IgE (Fig. 6E). In
contrast, control mice did not show detectable levels of human IgA
or IgE (Fig. 6D&E, Table S1). The results demonstrated that
human B cells developed by DRAG were functional as they
secreted all human immunoglobulin classes, whereas those from
control mice were impaired in their ability to undergo class
switching and secreted only IgM.
Human B cells develop by DRAG mice respond to tetanus
toxoid immunization
A major function of the immune system is to protect against
infections by eliciting specific antibodies that bind to and eliminate
pathogens. Tetanus toxoid, a formalin-detoxified form of Clostrid-
ium tetani toxin adjuvanted in alumn, is a licensed human vaccine
that induces neutralizing anti-tetanus toxin (TT) IgG antibodies.
We investigated whether human B cells from DRAG mice could
elicit specific humoral responses upon immunization with TT
vaccine. Groups of HSC-infused DRAG and control mice were
immunized with 1 flocculation unit of TT vaccine (Sanofi Pasteur)
by the intramuscular route, and the titers of anti-TT IgG Abs were
Figure 5. Kinetics of human B cell reconstitution in blood of DRAG and control mice. DRAG (n=15) and control (n=11) mice as in figure 1
were examined in peripheral blood by FACS using human CD19 Abs. The cut-off for positive human B cells was calculated as three times the standard
deviation over the background of cells from naı ¨ve (non-HSC infused) DRAG mice stained with CD19 antibodies (.0.18%). Panel A, percentage of
human B cell reconstituted mice at various time points post-infusion of HSC. Fisher exact test indicated that the rate of human B-cell reconstitution in
DRAG mice (14 out of 15) was similar to that of control mice (9 out 11) (p=0.54). Panel B, frequency of human B cells in blood of reconstituted DRAG
(n=14) and control (n=9) mice (p=0.31, Mann-Whitney test). Panels C and D, plasma values of human IgM and IgG respectively in B-cell
reconstituted DRAG (n=14) and control (n=9) mice at various time points post-infusion of HSC (p values 0.0002 and ,0.0001, Mann-Whitney test).
Data represent mean values of mice analyzed individually. Ranges are indicated over the plots.
doi:10.1371/journal.pone.0019826.g005
HLA Class II and Humanized Mice
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immunized-DRAG mice were able to elicit anti-TT IgG
antibodies, whereas the control mice failed to do so. These results
clearly indicated that human B cells developed by DRAG mice are
fully functional. In addition, the results demonstrated that the
‘‘human immune system’’ developed by DRAG mice is superior to
that developed by BLT mice, currently referred as the golden
standard for humanized mice, since the BLT mice cannot elicit
specific IgG antibodies upon TT immunization [26].
Discussion
The critical role of thymus in T cell development was revealed
in the 1930s when a line derived from CB.17 mice, nicknamed
‘‘nude’’ mice due to alopecia, was found athymic and unable to
repopulate peripheral lymphoid organs with mature T cells [38].
Subsequent studies demonstrated that surgical removal of the
thymus in neonatal mice reduced the numbers of mature T cells in
the periphery as well [39]. These studies also demonstrated the
critical role of T cells in commanding humoral responses, since
both ‘‘nude’’ and thymectomized neonatal mice are impaired in
eliciting antibodies, though they develop normal numbers of B
cells. Studies by Zinkernagel and others further demonstrated a
critical role of MHC molecules in the development and function of
T cells through a process of thymic selection [40]. In this study, we
demonstrated that transgenic expression of HLA class II (DR4)
molecules in NOD.Rag1KO.IL2RccKO mice rescues the devel-
opment and function of human T and B cells upon infusion of
adult mice with HSC from HLA-DR-matched umbilical cord
bloods. The rates of T cell reconstitution and frequencies of
human CD4 T cells in DRAG mice were significantly superior to
those in control NOD.Rag1KO.IL2RccKO mice (lacking HLA-
DR4 molecules) that were infused with HSC from the same
donors. The significant difference between DRAG and control
mice was solely associated with expression of HLA-DR4
molecules. The HLA-DR4 molecules thus promoted (i) efficient
human HSC engraftment in bone marrow, (ii) thymic develop-
ment of bone marrow-derived human pro-T cells, (iii) proficient
thymic selection of human thymocytes, and (iv) export of high
numbers of terminally differentiated human CD4 T cells and
Tregs to the periphery.
Figure 6. B cells from DRAG mice undergo immunoglobulin class switching. Panels A and B, immunoelectrophoresis of plasma proteins
from DRAG mice at 6 months post-infusion of HSC or prior to infusion with HSC, respectively. Panel C, percentage of human IgG subclasses within the
total human IgG fraction in plasma of six DRAG mice examined. Panel D, 12 out 14 (85.7%) DRAG mice that showed human B cells in blood,
reconstituted human IgA in plasma. Data present mean values of mice analyzed individually. Panel E, 7 out of 14 (50%) DRAG mice also reconstituted
human IgE in plasma. No human IgA or IgE was detected in plasma of control mice (p values ,0.0001 and 0.015, respectively by Mann-Whitney test).
doi:10.1371/journal.pone.0019826.g006
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class II antibodies prevent bone marrow engraftment in dogs [41]
and inhibit differentiation of cultured human HSCs in vitro [42].
Furthermore, human studies showed that HLA-DR compatibility
increases the engraftment efficiency in bone marrow transplants
[43]. As shown in our study, expression of HLA-DR4 molecules in
the bone marrow of DRAG mice favored early engraftment and
expansion of HLA-DR-matched HSC, while control mice lacking
expression of HLA-DR4 and infused with the same HSCs failed to
do so. The mechanisms by which HLA-DR4 expression in the
mouse bone marrow environment promote early engraftment of
human HSC remains to be investigated.
Our results also argue against the hypothesis that the adult
mouse thymus, which is characterized by a loss of the structural
and hormonal milieu, is unable to sustain development and
differentiation of human T cells [19]. This is because the adult
thymus of HSC-infused DRAG mice allowed engraftment and
development of a large number of human thymocytes and
exported mature CD4 T cells to periphery. Of note, the low rate
of human T cell reconstitution in our control (NOD.Rag1-
KO.IL2RccKO) mice (36%) was similar to that reported in studies
using NOD.scid.IL2RccKO mice [18,19], which further validates
the superiority of DRAG mice for reconstitution of human T cells.
Almost all DRAG mice (14 out of 15) developed human CD8 T
cells as compared to only 4 out 11 control mice. This was an
interesting finding, since DRAG mice do not express HLA class I
molecules, the restriction element for thymic differentiation of
human CD8 T cells. Recently, NOD.scid.IL2RccKO mice
expressing HLA class I (A2) molecules have been generated [27–
29]. Interestingly enough, the transgenic expression of HLA-A2
molecules did not improve the rates of human CD8 T cell
reconstitution as compared to non-transgenic littermates, though
the human CD8 T cells developed by some of the transgenic mice
were restricted by HLA-A2 molecules. Thus, expression of HLA
class I molecules does not suffice for promoting engraftment of
pro-T cells derived from bone marrow and efficient development
of human T cells, whilst expression of HLA class II does. The
superiority of DRAG mice in developing human CD8 T cells as
compared to our control mice and HLA-A2 Tg mice [27–29]
suggests the possibility that human CD8 T cells developed by
DRAG could have been educated and restricted by HLA class II
molecules. This remains to be further investigated.
Secondly, human T cells developed by DRAG mice were as
functional as those from healthy human volunteers, since they
vigorously responded to CD3/CD28 cross-linking and PMA/
ionomycin stimulation by secretion of human Th1 and Th2
cytokines (IL-2, IFNc, TNFa, IL-6, IL-5, and IL-4), whereas
human T cells from control mice failed to do so. Our results in
control mice are in agreement with numerous studies on
NOD.scid.IL2RccKO mice showing human T cell functional
impairment [15,18,20–22]. CD3/CD28 Abs stimulate T cells by
crosslinking TCR and CD28 co-receptor followed by activation of
ZAP70 intracellular signaling pathway that ultimately leads to the
transcriptional activation of genes involved in T cell differentiation
and cytokine secretion [44]. On the other hand, PMA/ionomycin
stimulates T cells by inducing calcium influx, thereby bypassing
TCR signaling pathways [45]. Our results clearly indicated that
expression of HLA-DR4 molecules in DRAG mice promoted the
development of human CD4 and CD8 T cells with preserved
integrity of both TCR and non-TCR signaling pathways.
It has been suggested that low frequency and functional
unresponsiveness of human T cells from humanized IL-2RccKO
genetic stocks lacking expression of HLA class II molecules maybe
due to a high level of FAS receptor (CD95) expression on T cells,
thereby increasing susceptibility to T cell death [18]. We found
that the level of CD95 expression on reconstituted human T cells
from DRAG and control mice was similar (MFI CD3 T cells:
20.5561.06 vs. 18.460.42; CD4 T cells 2261.55 vs. 19.160.98;
CD8 T cells: 19.260.98 vs. 15.961.94, respectively). Therefore, it
is unlikely that Fas-FasL induced apoptosis plays an important role
in elimination of mature T cells, which might account for the low
rates of T cell reconstitution and T cell numbers in our control
mice or other similar humanized mouse strains lacking expression
of HLA-DR4 molecules. Rather, the low human T cell
reconstitution rate in our control mice is attributed to inefficient
engraftment of pro-T cells derived from bone marrow and poor
thymic selection of human thymocytes.
Thirdly, though expression of HLA-DR4 molecules in DRAG
mice did not affect the reconstitution levels with human B cells as
compared to control mice, the B cells developed by DRAG mice
were functional and able to reconstitute serum levels of human
IgM comparable to those in human sera, whereas the levels of
human IgM in control mice were significantly lower (p=0.0002).
More importantly, the human B cells from DRAG mice were able
to undergo immunoglobulin class switching and to secrete IgG,
IgA, and IgE. In contrast, the B cells from our control mice, and
other similar genetic stocks [15,18,20–22] could only secrete low
levels of human IgM and were impaired for undergoing
immunoglobulin class switching.
Two categories of antigens can activate B cells, and they are
defined as T-cell independent or T-cell dependent antigens based
on their ability to induce antibodies in athymic (nude) mice that
lack mature T cells [24]. T-cell independent antigens are
polyclonal B cell activators, such as bacterial polysaccharides
and other components of the bacteria cell wall that act mainly
through toll-like-receptors (TLR) rather than through the B cell
receptor (surface Ig). Humoral responses to T-cell independent
antigens are mainly of IgM class as they do not required CD4 T
cell help. On the other hand, most antigens are T-cell dependent,
meaning that CD4 T cell help is required for immunoglobulin
class switching and antibody production. Unlike the T-cell
independent antigens, activation of B cells by T-cell dependent
Figure 7. DRAG mice respond to tetanus toxoid (TT) vaccina-
tion. Groups of DRAG and control mice (n=3) were immunized
intramuscularly with 1 flocculation unit of TT vaccine, and plasma levels
of human anti-TT IgG titers were measured by ELISA at day 14 post-
immunization. The frequency of human T and B cells in blood and
plasma levels of human immunoglobulins prior to TT-immunization are
shown in Table S1.
doi:10.1371/journal.pone.0019826.g007
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with the B cell receptor and the second from soluble factors
secreted by CD4 T cells, such as IL-4, IL-6, or IL-21 [46–48]. The
role of these cytokines in promoting B cell activation and
immunoglobulin class switching has been demonstrated in IL-
21R/IL-4 double deficient mice, which can only secrete IgM [49],
and also in IL-6 transgenic mice that develop plasmocytosis and
hyper-IgG globulinemia [50]. The ability of DRAG mice to
generate functional human T cells able to secrete cytokines
required for immunoglobulin class switching may account for the
development of functional human B cells that reconstituted serum
levels of human natural antibodies of all classes and subclasses.
Importantly enough, our study also demonstrated that the human
immune system developed by DRAG mice elicited specific IgG
antibodies upon immunization with tetanus toxoid vaccine. Our
vaccinated-control mice were however unable to do so, and this is
in agreement with previous studies in IL2RccKO genetic stocks
lacking HLA class II molecules that were also severely impaired for
eliciting human IgG responses to vaccination [15,20–22,26–28].
In summary, our results demonstrated that expression of HLA
class II molecules in humanized mice is critical for development of
functional human T and B cells able to efficiently respond to
vaccination. DRAG mice represent a new in vivo model for studies
on human T and B cell development and function, vaccine testing,
and generation of human IgG monoclonal antibodies for
prophylactic and/or therapeutic use.
Materials and Methods
Ethics Statement
All animal procedures reported herein were conducted under
IACUC protocols (ID numbers: D03-07, D06-07 and D07-10)
approved by WRAIR/NMRC and in compliance with the Animal
Welfare Act and in accordance with the principles set forth in the
‘‘Guide for the Care and Use of Laboratory Animals,’’ Institute of
Laboratory Animals Resources, National Research Council,
National Academy Press, 1996. The protocol for human use was
approved by the Naval Medical Research Center Institutional
Review Board in compliance with all applicable Federal
regulations governing protection of human subjects. De-identified
human blood samples were obtained through commercial vendors.
DRAG mice
C57BL/6 mice expressing transgenically HLA-DR4 (HLA-
DR*0401/I-E
d) molecules under the mouse I-E
d promoter were
purchased from Taconic (Hudson, NY) and backcrossed with
NOD.Rag1KO mice (The Jackson Labs, Bar Harbor, Maine) for
12 generations. Litters from F2-F12 generation were screened for
HLA-DR4/I-E
dab transgenes by PCR using specific primers for
HLA-DR4a (forward, AATCCTGACCAATCAGGCGAG, re-
verse, GCGGAAGAGGTGATCGTCCCT) and HLA-DR4b
(forward, GTTTCTTGGAGCAGGTTAAAC; reverse, CTGC-
ACTGTGAAGCTCTCAC) transgenes. Rag1KO litters were
identified by the absence of CD3
+ T cells upon staining of
peripheral blood cells with anti-mouse CD3 (Beckton Dickinson,
San Jose, CA). The level of inbreeding of F12 mice in NOD
background was 100% as determined by microsatellite analysis
(Mappairs, Diversified Biopharma Solutions Inc, Loma Linda,
CA). F12: HLA-DR4 Tg. NOD.Rag1KO males were crossed with
NOD.Rag1KO.IL2RccKO females (The Jackson Laboratories)
and male progeny was screened for HLA-DR4 transgenic (the
IL2Rcc gene is located in the X chromosome). Positive males were
crossed with NOD.Rag1KO.IL2RccKO females and all progeny
was screened for HLA-DR4ab transgenes. The HLA-DR4 (+/2)
Tg.NOD.Rag1KO.IL2RccKO (referred as DRAG) mice were
maintained in the pathogen-free WRAIR Veterinary Medicine
Facility.
Infusion of mice with HSC
Umbilical cord bloods (UCB) were purchased from AllCells
(Emeryville,CA) and Promocell (Heidelberg, Germany). Screening
for HLA-DRB1*0401 allele was carried out using DRB1*04 SSP
Unitray (Invitrogen, San Diego, CA). HLA-DRB1*0401-positive
cord bloods were enriched for CD34
+ stem cells using EasySep,
Human Progenitor Cell Enrichment kit (StemCell Technologies,
Vancouver, BC). Prior to enrichment, the frequency of CD34
+
cells in UCBs was 1.060.5% and after enrichment 62.068.6%.
Mice were irradiated (350 rads), and injected with 8610
4 CD34
+-
enriched HSC cells by the intravenous route. For longitudinal
analyses, we used groups of DRAG mice (n=15) and control
littermates (n=11) that were infused with HLA-DR4-positive cord
bloods from the same donors. For cross-sectional analyses we used
additional groups of mice that were euthanized at 2 months or 6
months post-infusion of HSCs.
FACS analysis
Blood drawn for the tail vein (20 ml) was collected with heparin-
coated capillary tubes (Fisher Scientific, Pittsburgh, PA). Erythro-
cytes were lysed using ACK lysis buffer (InVitrogen) and white
blood cells were incubated with Fcblock (BD Biosciences, San Jose,
CA) for 10 minutes at 4uC, and then stained with anti-human
CD3, CD4, CD8, and CD19Abs (BD Biosciences) for 30 minutes
at 4uC, washed with PBS/1% BSA/0.1% Na azide and analyzed
by FACS on the mononuclear FSC/SSC scatter. As control, we
used human peripheral blood from adult healthy volunteers that
was collected in heparin-coated tubes and treated as above. Mouse
splenic and thymic cells were obtained as described [31,33,51] and
bone marrow cells were obtained by flushing both tibias. Cell
populations were quantified by FACS as above using anti-human
CD3, CD4, CD8, CD19, CD45, CD34, CD95, CD11c, CD16,
HLA-DR (BD Biosciences) and FOXP3 (eBiosiences, San Diego,
CA).
T cell responses
Splenic cells (3610
5) from mice or PBMCs (3610
5) from
volunteers were stimulated for 24 h with anti-human CD3/CD28-
coated magnetic beads (InVitrogen), 1 mg/ml PMA plus 50 nM
iomycin (Sigma), or left unstimulated. Cytokines in supernatants
were measured by Luminex (InVitrogen).
Cell depletion and isolation
Spleen cells adjusted to 3610
6 cells/ml were depleted of CD4 T
cells, CD8 T cells, or both cell subsets with antibody-coated
magnetic beads (Dynabeads, InVitrogen). The efficiency of cell
depletion was .95% as measured by FACS using CD3, CD4, and
CD8 Abs. Equal volumes (0.1 ml) of cell depleted cell suspensions
or corresponding volumes of positively isolated cells on the
magnetic beads were stimulated with PMA/iomycin for 24 h and
cytokine secretion in cell culture supernatants were measured by
Luminex (InVitrogen).
ELISA
Peripheral blood from mice or humans was collected in heparin-
coated capillaries and plasma samples were obtained by removal
of cells by centrifugation. Total plasma immunoglobulins (IgM,
IgG, IgA and IgE) were measured by ELISA Quantitation Sets
(Bethyl Labs, Montgomery, Texas). Human IgG subclasses were
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gen). To determine titers of anti-TT IgG titers, ninety-six-well
plates were coated with 10 mg/ml of tetanus toxin (Calbiochem,
La Jolla, CA) in carbonate buffer for 2 h at RT. Plates were
washed (ELISA Wash Solution, Bethyl Labs), blocked (ELISA
Blocking solution, Bethyl Labs) for 30 min at RT, washed again,
and incubated with plasma samples at serial half dilutions starting
at 1:50. After 1 h incubation at RT, plates were washed and
incubated with anti-human IgG-HRP Abs (Bethyl Labs) for 1 h at
RT, washed, and revealed with Enzyme substrate (TMB, Bethyl
Labs) in dark for 15 minutes. The enzymatic reaction was stopped
(ELISA stop solution, Bethyl Labs) and plates were immediately
read at 450 nm. After plotting the OD values against plasma
dilution, the titers were calculated as the prior greatest dilution
over a two-fold standard deviation over the background.
Immunoelectrophoresis
Visualization of human immunoglobulin classes and immuno-
globulin light (kappa and lambda) chains was carried out using IEF
kits (Helena Labs, Beaumont, TX).
Immunization with tetanus toxoid
Tetanus toxid vaccine was obtained from the Naval Hospital,
Bethesda, MD. Mice were injected intramuscularly with 1
floculation unit (fl).
Statistical analysis
Comparison of cell reconstitution rates was carried out using
Fisher’s exact test. Comparison of cell frequencies and level of
immunoglobulins was determined by Mann-Whitney test. For
analysis of low number of samples we used the Independent
Samples t-test.
Supporting Information
Table S1 Human reconstitution in blood of DRAG and
control mice upon infusion of HLA-DR*0401 hemato-
poietic stem cells. (*) human cell frequencies measured at 25
weeks post-infusion of HSC. (
#) concentration of plasma levels of
human IgM and IgG (32 weeks post-infusion of HSC) and IgA and
IgE (25 weeks post-infusion of HSC). (
&) mice were immunized
with TT at week 31 post-infusion of HSC. (ND) not done.
(DOCX)
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